Patients with lymphoma treated with B-cell-depleting therapies may have worse outcomes from COVID-19 infection
Among patients with lymphoma admitted to the hospital for severe COVID-19, those treated with B-cell-depleting therapies within the previous 12 months had an increased risk of prolonged hospital stay and death, according ...
Feb 4, 2021
0
3